84327-80-0

Basic information

• Product Name: N-(4-bromophenyl)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)sulfanylacetamide
• Synonyms: N-(4-bromophenyl)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)sulfanylacetamide
• CAS NO: 84327-80-0
• Molecular Weight: 424.705
• Mol File: 84327-80-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(4-bromophenyl)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)sulfanylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-bromophenyl)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)sulfanylacetamide(84327-80-0)
• EPA Substance Registry System: N-(4-bromophenyl)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl)sulfanylacetamide(84327-80-0)

Safety Data

• Hazardous Substances Data: 84327-80-0(Hazardous Substances Data)

Upstream product

• 74-11-3 para-chlorobenzoic acid 
• 5439-13-4 N-(4-bromophenyl)-2-((2-((4-cyanophenyl)amino)-6-methylpyrimidin-4-yl)oxy)acetamide 
• 23766-28-1 5-(4-chlorophenyl)-1,3,4-oxadiazole-2-thiol 
• 23766-28-1 5-(4-chlorophenyl)-2,3-dihydro-1,3,4-oxadiazole-2-thione 
• 2564-02-5 N-(4-bromophenyl)-2-chloroacetamide 
• 536-40-3 4-chlorobenzoic acid hydrazide 
• 106-40-1 4-bromo-aniline 

Relevant articles and documents

Antiviral and Antibacterial Activities of N-(4-Substituted phenyl) Acetamide Derivatives Bearing 1,3,4-Oxadiazole Moiety

In this paper, a series of N-(4-substituted phenyl) acetamide derivatives bearing 1,3,4-oxadiazole moiety were synthesised. Preliminary bioassays revealed that these compounds not only exhibited favourable antiviral activities toward tobacco mosaic virus (TMV) but also demonstrated sustained inhibition activities against plant pathogenic bacteria, including Xanthomonas oryzae pv. oryzae, Ralstonia solanacearum, and Xanthomonas axonopodis pv. citri. Among the derivatives, TC8and TC20exerted the strongest curative activities against TMV, with half-maximal effective concentration (EC50) values of 239.5 and 236.2 μg/mL, respectively, which were comparable to that of ningnanmycin (EC50=273.2 μg/mL). Given their simple synthesis, the target compounds can serve as alternative antiviral candidates.

Synthesis of some new heterocyclic 1,3,4-oxadiazoles with antibacterial activity

-